[Integrated treatment of psychosis: combination of psychopharmacology and psychotherapy].
Over the initial period of its clinical use, the effectiveness of neuroleptics determined a relative decline of the psychotherapeutic approaches to the psychoses. However, recent evidence shows that combined pharmacological-psychotherapeutic treatment may increase therapeutic potency. The specific psychodynamics of psychotic syndromes requires the association of different psychotherapeutic techniques and patient management approaches to pharmacological treatment.
González de Rivera y Revuelta
J L
JL
Catedrático de Psiquiatría, Universidad de la Laguna.
D002220:Carbamazepine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D010554:Personality Disorders / Q000188:drug therapy / Q000628:therapy; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000188:drug therapy / Q000628:therapy*; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy; D014635:Valproic Acid / Q000627:therapeutic use*
D002220:Carbamazepine; D014635:Valproic Acid
El tratamiento integrado de la psicosis: combinación de psicofármacos y psicoterapia.